Antibiyotiklere Alternatif Terapi: CRISPR-Cas antimikrobiyalleri
Gene Editing · 2020
DOI: 10.29228/genediting.41450 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Editing, 2020. Verfasst von CIHAN TASTAN- Aysegul Ates und 1 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
with the spread of "pan-resistant" strains identified as resistant to all classes of antibiotics is seen as alarming. Infectious diseases can’t be treated due to antibiotic resistance, which develops due to unnecessary antibiotic use, wrong antibiotic selection, wrong dose and irrational use of antibiotics. The efficacy of antimicrobial drugs decreases due to Antibiotics affect specific mechanisms of bacteria by targeting cellular pathways or functions such as function of cell membrane, blockage of cell wall synthesis, protein or nucleic acid synthesis. They can’t selectively kill targeted pathogens in the mixed microbial population with these mechanisms. Antibiotics cause dysfunction not only of the bacteria that cause infection but also of the beneficial microbiota members in the host. Currently, there is no specific antibiotic strategy targeting only virulent or antibiotic-resistant bacteria. Current antibiotic strategies aren’t specific; resistant bacteria allow spread of the resistance genes in the bacterial population. Recently, new molecular techniques have been introduced to deal with antimicrobial resistance. Researchers could knock out plasmid-mediated antibiotic resistance genes in order to prevent the spread of resistance. This review will discuss antibiotic resistance, CRISPR-Cas9 gene editing mechanism and its applications against bacteria itself, which will be an important method to prevent the clonal spread of resistant strains, providing a unique solution to the global problem.
Zitieren
APA
Ates, C. T. A., & Ermertcan, S. (2020). Antibiyotiklere Alternatif Terapi: CRISPR-Cas antimikrobiyalleri. Gene Editing. https://doi.org/10.29228/genediting.41450
Vancouver
Ates CTA, Ermertcan S. Antibiyotiklere Alternatif Terapi: CRISPR-Cas antimikrobiyalleri. Gene Editing. 2020. doi:10.29228/genediting.41450
BibTeX
@article{Ates2020,
author = {Ates, CIHAN TASTAN- Aysegul and Ermertcan, Safak},
title = {Antibiyotiklere Alternatif Terapi: CRISPR-Cas antimikrobiyalleri},
journal = {Gene Editing},
year = {2020},
doi = {10.29228/genediting.41450}
}
EUVIMED